146 related articles for article (PubMed ID: 35984840)
21. PRODeepSyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein-protein interaction network.
Wang X; Zhu H; Jiang Y; Li Y; Tang C; Chen X; Li Y; Liu Q; Liu Q
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35043159
[TBL] [Abstract][Full Text] [Related]
22. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
23. Network Propagation Predicts Drug Synergy in Cancers.
Li H; Li T; Quang D; Guan Y
Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
[TBL] [Abstract][Full Text] [Related]
24. In silico drug combination discovery for personalized cancer therapy.
Jeon M; Kim S; Park S; Lee H; Kang J
BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
[TBL] [Abstract][Full Text] [Related]
25. Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network.
Liu L; Chen X; Hu C; Zhang D; Shao Z; Jin Q; Yang J; Xie H; Liu B; Hu M; Ke K
Sci Rep; 2018 May; 8(1):8440. PubMed ID: 29855504
[TBL] [Abstract][Full Text] [Related]
26. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
27. Deep graph embedding for prioritizing synergistic anticancer drug combinations.
Jiang P; Huang S; Fu Z; Sun Z; Lakowski TM; Hu P
Comput Struct Biotechnol J; 2020; 18():427-438. PubMed ID: 32153729
[TBL] [Abstract][Full Text] [Related]
28. DrugComboRanker: drug combination discovery based on target network analysis.
Huang L; Li F; Sheng J; Xia X; Ma J; Zhan M; Wong ST
Bioinformatics; 2014 Jun; 30(12):i228-36. PubMed ID: 24931988
[TBL] [Abstract][Full Text] [Related]
29. Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.
Han K; Jeng EE; Hess GT; Morgens DW; Li A; Bassik MC
Nat Biotechnol; 2017 May; 35(5):463-474. PubMed ID: 28319085
[TBL] [Abstract][Full Text] [Related]
30. A novel network based linear model for prioritization of synergistic drug combinations.
Li J; Xu H; McIndoe RA
PLoS One; 2022; 17(4):e0266382. PubMed ID: 35381038
[TBL] [Abstract][Full Text] [Related]
31. Exploration of Target Synergy in Cancer Treatment by Cell-Based Screening Assay and Network Propagation Analysis.
Naveja JJ; Stumpfe D; Medina-Franco JL; Bajorath J
J Chem Inf Model; 2019 Jun; 59(6):3072-3079. PubMed ID: 31013082
[TBL] [Abstract][Full Text] [Related]
32. Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin.
Skripova V; Vlasenkova R; Zhou Y; Astsaturov I; Kiyamova R
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209078
[TBL] [Abstract][Full Text] [Related]
33. Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge.
Ding P; Yin R; Luo J; Kwoh CK
IEEE J Biomed Health Inform; 2019 May; 23(3):1336-1345. PubMed ID: 29994408
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives.
Chan YT; Lu Y; Wu J; Zhang C; Tan HY; Bian ZX; Wang N; Feng Y
Theranostics; 2022; 12(7):3329-3344. PubMed ID: 35547744
[TBL] [Abstract][Full Text] [Related]
35. Computational methods, databases and tools for synthetic lethality prediction.
Wang J; Zhang Q; Han J; Zhao Y; Zhao C; Yan B; Dai C; Wu L; Wen Y; Zhang Y; Leng D; Wang Z; Yang X; He S; Bo X
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35352098
[TBL] [Abstract][Full Text] [Related]
36. Precise Characterization of Genetic Interactions in Cancer via Molecular Network Refining Processes.
Jung J; Hwang Y; Ahn H; Lee S; Yoo S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681774
[TBL] [Abstract][Full Text] [Related]
37. GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning.
Muslu O; Hoyt CT; Lacerda M; Hofmann-Apitius M; Frohlich H
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(1):491-500. PubMed ID: 32750869
[TBL] [Abstract][Full Text] [Related]
38.
Sun N; Petiwala S; Lu C; Hutti JE; Hu M; Hu M; Domanus MH; Mitra D; Addo SN; Miller CP; Chung N
CRISPR J; 2019 Aug; 2():230-245. PubMed ID: 31436504
[TBL] [Abstract][Full Text] [Related]
39. A Comparative Study of Cluster Detection Algorithms in Protein-Protein Interaction for Drug Target Discovery and Drug Repurposing.
Ma J; Wang J; Ghoraie LS; Men X; Haibe-Kains B; Dai P
Front Pharmacol; 2019; 10():109. PubMed ID: 30837876
[TBL] [Abstract][Full Text] [Related]
40. DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations.
Hu J; Gao J; Fang X; Liu Z; Wang F; Huang W; Wu H; Zhao G
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35915050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
